Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Public Health Burden of Antimicrobial Resistant Streptococcus Pneumoniae, Panel 1, Potential Extramural Project (PEP), R02

---
identifier: "/us/fr/05-12071"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Public Health Burden of Antimicrobial Resistant Streptococcus Pneumoniae, Panel 1, Potential Extramural Project (PEP), R02"
title_number: 0
title_name: "Federal Register"
section_number: "05-12071"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Public Health Burden of Antimicrobial Resistant Streptococcus Pneumoniae, Panel 1, Potential Extramural Project (PEP), R02"
positive_law: false
currency: "2005-06-20"
last_updated: "2005-06-20"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "05-12071"
document_type: "notice"
publication_date: "2005-06-20"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "70 FR 35445"
fr_volume: 70
---


#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Public Health Burden of Antimicrobial Resistant Streptococcus Pneumoniae, Panel 1, Potential Extramural Project (PEP), R02

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:

*Name:* Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Public Health Burden of Antimicrobial Resistant Streptococcus Pneumoniae, Panel 1, Potential Extramural Project (PEP), R02.

*Times and Dates:* 1:30 p.m.-3 p.m., July 11, 2005 (Closed).

*Place:* Teleconference.

*Status:* The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

*Matters To Be Discussed:* The meeting will include the review, discussion, and evaluation of applications received in response to: Public Health Burden of Antimicrobial Resistant Streptococcus *Pneumoniae* , Panel 1, Potential Extramural Project (PEP), R02.

*Contact Person for More Information:* J. Felix Rogers, Ph.D., M.P.H., Scientific Program Administrator, National Immunization Program, CDC, 1600 Clifton Road NE., Mailstop E-05, Atlanta, GA 30333, Telephone 404.639.6101.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: June 13, 2005.

Alvin Hall,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.